Pharma News Archive

Pharma News: March 2008

March 3	New survey shows Michigan doctors embracing ePrescribing
March 3	Toolbar Created for PharmaLiveSearch.com, the Only Search Engine Specific to the Pharmaceutical Industry
March 3	AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
March 3	Pfizer to Acquire Serenex to Extend Oncology Pipeline and Access Novel Technology Platform
March 3	Merck Progress Report on Enrollment in Program to Resolve U.S. Vioxx Product Liability Lawsuits
March 3	MicroDose Technologies Grants Global License to Merck & Co., Inc., for Use of the MicroDose Inhaler with Merck's Proprietary Products
March 3	OneWorld Health, Amyris Biotechnologies and sanofi-aventis Announce Development Agreement for Semisynthetic Artemisinin
March 3	BioWa Announces Expansion of License Agreement with Genentech for BioWa's POTELLIGENT Technology
March 3	Barr Announces Favorable Ruling in Yasmin Patent Challenge
March 4	StemCells, Inc. Terminates Its Discussions to Acquire Progenitor Cell Therapy, LLC
March 4	Court Decides Against Bayer’s Yasmin Patent
March 4	Allergan Comments on the United States Department of Justice Subpoena for the Production of Documents Relating to Promotional Practices of Botox for Therapeutic Uses
March 4	PsychoGenics and Dainippon Sumitomo Pharma Sign Drug Discovery Agreement
March 4	New Technique Involving Roche's LightCycler 480 Instrument Enables Efficient and Economic Studies on RNA Editing
March 4	Senate President Announces Major Legislation to Advance Massachusetts Health Care Reform
March 4	Astellas to Move Clinical Development Base to U.S.
March 4	Provectus Pharmaceuticals Receives US Patent Allowance to Provide Further Protection for Novel Photodynamic Drug PH-12
March 4	Medwatch: Tamiflu (oseltamivir phosphate)
March 4	Breast Cancer Risk Lingered Years after Women Discontinued Estrogen-Progestin Therapy, Stanford Researcher Says
March 4	WHI Findings Published in JAMA Do Not Affect Clinical Guidance for the Appropriate Use of Hormone Therapy
March 5	Pfizer Presents New Opportunities for Global Growth
March 5	Medicure Announces Corporate Restructuring
March 5	PDL BioPharma Ends Sale Process for Company and Restructures to Focus on Antibody Discovery and Development
March 6	Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
March 6	IMPAX Comments on Lawsuit Related to Generic Version of Detrol LA
March 6	Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
March 6	IMPAX Comments on Lawsuit Related to Generic Version of Detrol LA
March 6	GSK Statement on MHRA Investigation
March 6	GSK Investigation Concludes
March 6	Sensor Necklace Aims to Increase Drug Compliance
March 6	FDA Updates Safety Information for Long Acting Beta Agonists
March 6	Mental Health Parity Laudable, But House Legislation Would Put Medicaid Patients at Risk, Lilly Says
March 6	PhRMA Statement on Mental Health Parity Legislation
March 6	Celgene and Pharmion Announce Shareholder Vote in Favor of Acquisition of Pharmion
March 6	Kennedy, Ramstad Announce Historic Passage of Paul Wellstone Mental Health Parity Bill
March 6	FDA Warns Companies Importing and Marketing Drugs Over the Internet that Fraudulently Claim to Prevent and Treat STDs
March 6	Marcadia Biotech, Inc. and Merck & Co., Inc. Enter Strategic Collaboration
March 6	Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
March 7	Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response
March 7	Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel
March 7	Alkermes Provides Update on Inhaled Insulin Program
March 7	Pfizer Wins Challenge to Two Main U.S. Patents for Celebrex by Generic Manufacturer Teva
March 7	AVANT Announces Completed Merger with Celldex and 1-for-12 Reverse Stock Split
March 10	Lilly Announces Termination of AIR Insulin Program
March 10	Immunicon Corporation Announces Corporate Restructuring
March 10	Cerimon to Conduct a Proof of Concept Study for Basiliximab for Noninfectious Uveitis, a Potentially Sight-Threatening Inflammation of the Eye
March 10	Amgen Announces Update to U.S. Prescribing Information for Aranesp and Epogen
March 10	Conclusion of Co-Development and Co-Marketing Agreement on Z-338 for Functional Dyspepsia in Japan with Astellas Pharma Inc.
March 10	Curis Announces Conclusion of Hedgehog Agonist Collaboration with Wyeth
March 10	A Successful 2007 Paves the Way for Future of Nycomed
March 10	Tongjitang Receives Proposal to Acquire All Outstanding Shares of the Company
March 10	Hagens Berman: Eleven Defendants Settle in Average Wholesale Price Litigation
March 11	Cytogen Announces Definitive Merger Agreement with EUSA PHARMA for $0.62 per Share in Cash
March 11	Totality of Available Data Reaffirms Procrit (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
March 11	OmniLytics Enters Collaboration with Elanco
March 11	FDA Names Permanent Director for Center for Drug Evaluation and Research
March 11	Congresswoman Schwartz Calls on EPA to Establish a National Taskforce to Investigate Pharmaceuticals in America’s Water Supply
March 11	Pipex Pharmaceuticals Announces Cost Reduction Measures
March 11	Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
March 11	Pfizer's Waxman to Leave
March 11	U.S. Patent Office Upholds Two Additional Human Embryonic Stem Cell Patents in Reexamination Decisions
March 12	Trial Date Set For Seroquel Patent Litigation
March 12	FDA approval of Abbott's Simcor marks start of co-promotion with Solvay
March 12	IMS Health Reports U.S. Prescription Sales Grew 3.8 Percent in 2007, to $286.5 Billion
March 12	FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of Provenge
March 12	Connecticut AG Blumenthal Sues Eli Lilly For Illegally Marketing Antipsychotic Drug Zyprexa For Unapproved Uses
March 12	China Aoxing Pharmaceutical Company Signed Definitive Acquisition Agreement to Acquire Shijiazhuang Lerentang Pharmaceutical Company, Ltd.
March 12	Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
March 12	Med Ad News Announces Nominees for the 19th Annual Manny Awards
March 12	Suven Establishes Second CNS Drug Discovery Collaboration with Lilly
March 12	M's Science and Eisai Sign Option Agreement for Sigma Agonist SA4503
March 12	FDA and Tibotec Dear Healthcare Professional Letter Regarding New Prescribing Information for Prezista (darunavir)
March 13	FDA MedWatch - Prezista (darunavir)- Reports Of Drug Induced Hepatitis In Patients Receiving Prezista/Ritonavir
March 13	FDA MedWatch- Erythropoiesis Stimulating Agents- Studies Indicate Increased Mortality And More Rapid Tumor Progression In Patients With Cancer Receiving ESAs
March 13	Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
March 13	Immtech Announces Update on Business Operations
March 13	Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report
March 13	Roche NimbleGen and Affymetrix Expand Licensing Agreement
March 13	Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
March 14	Option to Develop Exelixis Compound Exercised By Genentech
March 14	Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
March 14	Sen. Kohl Requests Documents from Schering-Plough Regarding “49 Plan” Sales Push
March 14	Genentech Provides Business Update at Annual Investment Community Meeting
March 14	Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
March 14	Ceragenix Completes Patient Visit Phase of Clinical Trial Study to Compare Efficacy of EpiCeram to Elidel
March 14	Bostwick Laboratories Announces Initial Public Offering
March 14	Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
March 17	FDA Takes Next Step in Establishing Overseas Presence
March 17	Merck Scientists Apply Innovative Research Method to Identify Changes in Gene Networks Linked to Obesity
March 17	Statement from Eli Lilly and Company: Response to Today's New York Times Article, 'Lilly E-Mail Discussed Off-Label Drug Use'
March 17	Reps. Eshoo, Barton Introduce Pathway for Biosimilars Act
March 17	FDA Indicates That Genasense Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data
March 17	Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel
March 17	As Problems Surface, Consumerlab.com and the People’s Pharmacy Ask FDA to Disclose Differences Between Generic and Original Drugs
March 17	Oriola-KD to Enter Growing Russian Pharmaceutical Retail and Wholesale Markets
March 17	Dynavax and Merck & Co., Inc. Report Clinical Hold of Investigational Vaccine Heplisav
March 18	Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline
March 18	OSI Pharmaceuticals Announces That the Prior Revocation of Its European DP-IV Patent Has Been Upheld
March 18	Baxter's Board of Directors Approves New Share Repurchase Authorization of $2 Billion
March 18	Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange
March 18	Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline
March 18	MedWatch - Tiotropium (marketed as Spiriva HandiHaler): Ongoing Safety Review - Possible Increased Risk of Stroke
March 19	Kosan Restructures Workforce to Focus Resources on Lead Clinical Programs
March 19	Former Intermune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations
March 19	Merck Serono Launches Cyanokit in Japan
March 19	Florida, 18 States Sue Abbott Laboratories for Blocking Generic Prescription Competition
March 19	Alkermes Announces Restructuring
March 19	Cenix BioScience Signs Framework Research Agreement with AstraZeneca for RNAi-Based Drug Discovery
March 19	Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
March 19	MedCap Urges Vote Against Proposed VaxGen Merger With Raven biotechnologies
March 20	European CHMP Issues Positive Opinion for Viread for the Treatment of Chronic Hepatitis B
March 20	Pharming To Receive Negative Opinion On European Marketing Authorization Application For Rhucin
March 20	Price of Medicine May Affect Its Efficacy According to Stanford Business School Research
March 20	Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
March 20	EPIX Pharmaceuticals Announces Discontinuation of PRX-00023 Clinical Development Program
March 20	UCB Advises US-Physicians to Down-Titrate Patients on Neupro In View of Out-of-Stock Situation in the US
March 20	Bellwether Industry’s Confidence In UK Slumps – ABPI/CBI Survey
March 20	Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
March 21	Federal Court of Appeal in Canada Upholds Lipitor Enantiomer Patent, Decision Prevents Launch of Generic Product by Ranbaxy until 2010
March 21	American Health Packaging Announces a Recall of Approximately 1,400 Units of Heparin Sodium Vial Products as Part of Broader Baxter Recall
March 21	EMEA Concludes New Advice to Doctors and Patients for Tysabri (natalizumab) Needed
March 21	EMEA Recommends New Contraindication for Velcade (bortezomib)
March 21	Opexa Therapeutics Announces Retirement of CEO David McWilliams
March 24	Free Drug Samples May Burden Patients' Pockets
March 24	CytRx Submits Response to FDA Related to Clinical Program with Arimoclomol in ALS
March 24	MedWatch - B. Braun Heparin Sodium Injection Solutions - Recall due to heparin-like contaminant
March 24	STG Media Corp. Combines Forces with Internet Solutions Provider Salient Digital, Inc. to Form STG Interactive
March 24	Biovail Reaches Settlement With SEC, Provides Update On OSC Investigation
March 24	R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007
March 24	Hagens Berman Sobol Shapiro: Nationwide Class Action Certified in Average Wholesale Price Litigation
March 24	R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007
March 25	Jama Editor-in-chief Comments on Pfizer Lawsuit
March 25	Sonus Pharmaceuticals Refines Strategic Initiatives
March 25	Drug Alerts Sent Instantly to U.S. Doctors via Email on New National Network
March 25	Health Care Services M&A Posts Second-Highest Dollar Level in 2007, According to Irving Levin Associates, Inc.
March 25	Shire plc: IFRS Results for the Year Ending December 31, 2007
March 26	Bayer Schering Pharma Starts New Campaign - Restore the Man
March 26	State of Alaska and Eli Lilly and Company Reach Agreement to Settle Zyprexa Lawsuit
March 26	Plastic Surgery Procedures Maintain Steady Growth in 2007
March 26	Evotec's Registration Statement in Connection With its Proposed Acquisition of Renovis Declared Effective
March 26	Surveys Find Key Changes in the Role of the Pharmaceutical CFO
March 26	FDA Makes Recommendations on Medical Devices That Treat Blocked Heart Arteries
March 27	FDA Sends Warning Letter to King Pharmaceuticals Over Avinza File Card
March 27	FDA Deadlines May Compromise Drug Safety by Rushing Approval
March 27	Pfizer Clears U.S. Antitrust Review for Acquisition of All Outstanding Shares of Encysive Pharmaceuticals Inc.
March 27	Aida Acquires High-Level Research Institute in China
March 27	Progen Restructures Manufacturing and Drug Discovery Divisions
March 27	Pegintron Plus Weight-Based Rebetol Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C
March 27	FDA MedWatch- Singulair (montelukast)- Possible Association Between Use Of Singulair And Behavior/Mood Changes, Suicidality, And Suicide
March 27	Phoenix Healthcare Reports on Cholesterol Patients' Reactions to Publicity and Press Stories
March 27	Otsuka to Pay More Than $4 Million to Resolve Off-Label Marketing Allegations Involving Abilify
March 27	FDA MedWatch- Regranex (becaplermin) Gel- Study Data Suggests Possible Increased Risk Of Death From Cancer In Diabetic Patients Using The Product
March 27	FDA MedWatch- Ziagen (abacavir) and Videx (Didanosine)- Study Date Indicates A Higher Risk of Heart Attack In Patients Infected With HIV-1 Taking Ziagen Or Videx
March 28	FDA issues a Communication about an Ongoing Safety Review Regranex (becaplermin)
March 28	VaxGen and Raven Terminate Merger Agreement
March 28	Otsuka to Pay More than $4 Million to Resolve off-label Marketing Allegations Involving Abilify
March 28	Discontinuation of Development of TAK-475, a Compound for Treatment of Hypercholesterolemia
March 28	Medicines Australia Sets World-First in Transparency
March 31	Teva to Acquire Bentley Pharmaceuticals
March 31	Verispan Reports: Physicians Prefer Merck's ePromotion Activities
March 31	Naglazyme Approved by Japanese Ministry of Health
March 31	Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor Patent

Pharma News Archive

2008: Jan | Feb | Mar | Apr | May
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources

Pharma News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals

	A to Z Drug List	Drugs by Condition	Pill Identifier	Drug Interactions Checker	Medical Encyclopedia	Medical Dictionary	Pharmaceutical News & Articles	Community Forums
Welcome Guest\|Register or Sign In My Viewing History \| My Drug List \| My Interactions Lists \| Member Offers